AWM
PTX

Avior Wealth Management’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

Avior Wealth Management’s Portfolio PTX Stock Details PTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-70
Closed – – 773
2018
Q4 		$0 Hold
70
– – ﹤0.01% 799
2018
Q3 		$0 Hold
70
– – ﹤0.01% 802
2018
Q2 		$0 Hold
70
– – ﹤0.01% 886
2018
Q1 		$0 Hold
70
– – ﹤0.01% 855
2017
Q4 		$0 Hold
70
– – ﹤0.01% 816
2017
Q3 		$0 Hold
70
– – ﹤0.01% 533
2017
Q2 		$0 Hold
70
– – ﹤0.01% 518
2017
Q1 		$0 Hold
70
– – ﹤0.01% 552
2016
Q4 		$0 Hold
70
– – ﹤0.01% 528
2016
Q3 		$0 Hold
70
– – ﹤0.01% 507
2016
Q2 		$0 Hold
70
– – ﹤0.01% 508
2016
Q1 		$1K Hold
70
– – ﹤0.01% 472
2015
Q4 		$2K Hold
70
– – ﹤0.01% 417
2015
Q3 		$2K Hold
70
– – ﹤0.01% 378
2015
Q2 		$4K Buy
+70
New +$4.94K ﹤0.01% 334

Avior Wealth Management's PTX Position: Q1 2019 in Review

Avior Wealth Management sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q1 2019, closing a stake of 70 shares.

Avior Wealth Management first reported a position in PTX in Q2 2015 and held it in 15 quarters. The position peaked at $4K in Q2 2015. 1 fund tracked by Wall St. Rank holds PTX as of Q1 2019.

  • Avior Wealth Management reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q1 2019 after selling out during the quarter.
  • Avior Wealth Management sold 70 Pernix Therapeutics Holdings, Inc. shares in Q1 2019.
  • Avior Wealth Management first reported a position in Pernix Therapeutics Holdings, Inc. in Q2 2015 and held it in 15 quarters.
  • Avior Wealth Management's Pernix Therapeutics Holdings, Inc. position peaked at $4K in Q2 2015.
  • 1 fund tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q1 2019.

Based on Avior Wealth Management's 13F filing for Q1 2019, filed 8 May 2019.